{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:02:37Z","timestamp":1791756157995,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Self-funded Scientific Research Project of the Health Commission of Guangxi Zhuang Autonomous Region","award":["No. Z-A20240099"],"award-info":[{"award-number":["No. Z-A20240099"]}]},{"name":"the Self-funded Scientific Research Project of the Health Commission of Guangxi Zhuang Autonomous Region","award":["No. Z-A20240116"],"award-info":[{"award-number":["No. Z-A20240116"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Elderly women with type 2 diabetes mellitus (T2DM) are at high risk of fragility fractures, particularly lethal hip fractures. Pathophysiologically, this elevated risk may be attributed to reduced nutritional reserves and dysregulation of the immune-inflammatory system. However, the fracture risk assessment tool (FRAX) often underestimates the 10-year probability of future fractures, as it does not fully account for these pathophysiological factors in this high-risk population. This study aims to determine whether the hemoglobin, albumin, lymphocyte, and platelet (HALP) score serves as an effective prognostic marker for a real-world fragility fracture endpoint, and whether incorporating the HALP score into FRAX improves the prediction of the 10-year probability of fragility fractures in this high-risk population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This ambispective longitudinal cohort study utilized multicenter retrospective cohort data collected between January 1, 2014, and January 1, 2016 (Phase 1), followed by prospective follow-up for fragility fracture endpoints from January 1, 2016, to January 1, 2021 (Phase 2). Follow-up was conducted via outpatient services and telephone interviews every six months, with a median follow-up duration of 46.8 months. A total of 423 participants were included in the present analysis. Based on HALP score tertiles, participants were divided into low (\u2264\u200931.98,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009141), moderate (31.98\u201348.08,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009140), and high (\u2265\u200948.08,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009142) groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 423 participants, 75 (17.73%) experienced real-world fragility fractures. Spearman\u2019s partial correlation analysis revealed a significant inverse association between the HALP score and the FRAX\u2011estimated 10\u2011year probability of hip fracture (FRAX\u2011HF) (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u2212\u20090.103,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.037), but no significant correlations with bone mineral density (BMD) and the FRAX\u2011estimated 10\u2011year probability of major osteoporotic fracture (FRAX\u2011MOF). Multivariate linear regression further quantified that each one\u2011tertile decrease in HALP (tertile interval\u2009=\u200916.1) was associated with an approximate 0.31% increase in FRAX\u2011HF probability (calculated as 0.019\u2009\u00d7\u200916.1\u2009=\u20090.3059) (\u03b2 = \u22120.019; 95% confidence interval [CI]: \u22120.034 to \u2212\u20090.005;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007). Notably, in the lowest HALP tertile, the FRAX\u2011HF increased from the overall baseline of 2.30% (moderate risk, requiring only lifestyle management) to 3.00% (high risk, warranting anti\u2011osteoporosis therapy), representing a relative increase of 30.43%. Consequently, all non\u2011osteoporotic participants in this tertile, whose initial hip fracture probability (2.3%) was below the guideline-recommended intervention threshold of 3%, met criteria for initiating anti\u2011osteoporosis treatment, resulting in an intervention rate of 27.13% (35\/129). These findings support the utility of combining the HALP score with FRAX for risk stratification to refine hip fracture prediction. Restricted cubic spline (RCS) analysis indicated dose\u2011dependent nonlinear relationships between HALP and overall fragility fracture endpoint events (Z\u2011shaped, overall\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0011), as well as between HALP and FRAX\u2011HF (L\u2011shaped, overall\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Multivariable Cox regression confirmed a significant inverse trend between HALP and the real\u2011world fragility fracture endpoint (\n                      <jats:italic>p<\/jats:italic>\n                      for trend\u2009=\u20090.002), and subgroup stratified analyses demonstrated stable predictive value across strata (all\n                      <jats:italic>p<\/jats:italic>\n                      for interaction\u2009&gt;\u20090.05). Kaplan\u2013Meier analysis illustrated a higher cumulative fracture incidence associated with lower HALP scores (log\u2011rank test,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.00037). Receiver operating characteristic (ROC) curve analysis identified an optimal HALP cut\u2011off of 46.77 for fragility fractures, with an area under the curve (AUC) of 0.643 and a sensitivity of 84.0% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings suggest that the HALP score may serve as an effective prognostic indicator for fragility fractures. Furthermore, the HALP score-adjusted FRAXplus tool (integrating the HALP score into FRAX) makes more elderly female patients with T2DM whose initial hip fracture probability falls below the guideline-recommended intervention threshold eligible for anti-osteoporosis therapy, thereby helping to reduce future 10-year hip fracture events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-026-02338-3","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:14:25Z","timestamp":1780499665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["HALP score-adjusted FRAXplus tool effectively predicts hip fracture risk in elderly women with type 2 diabetes mellitus"],"prefix":"10.1186","volume":"26","author":[{"given":"Wenxin","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangmei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0212-3624","authenticated-orcid":false,"given":"Wensheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"2338_CR1","doi-asserted-by":"publisher","unstructured":"Hong S, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Bruce B, Duncan, et al. IDF Diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022 Jan;183:109119. https:\/\/doi.org\/10.1016\/j.diabres.2021.109119.","DOI":"10.1016\/j.diabres.2021.109119"},{"issue":"2","key":"2338_CR2","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3390\/ijerph18020738","volume":"18","author":"R Hanna Elonheimo","year":"2021","unstructured":"Hanna Elonheimo R, Lange H, Tolonen. Marike Kolossa-Gehring. Environmental Substances Associated with Osteoporosis-A Scoping Review. Int J Environ Res Public Health. 2021;18(2):738. https:\/\/doi.org\/10.3390\/ijerph18020738.","journal-title":"Int J Environ Res Public Health"},{"key":"2338_CR3","doi-asserted-by":"publisher","unstructured":"Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross-sectional study. BMJ. 2020 Apr 28;369:m997. https:\/\/doi.org\/10.1136\/bmj.m997.","DOI":"10.1136\/bmj.m997"},{"issue":"10","key":"2338_CR4","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/jbmr.3757","volume":"34","author":"Q Zeng","year":"2019","unstructured":"Zeng Q, Li N, Wang Q, Feng J, Sun D, Zhang Q, et al. The Prevalence of Osteoporosis in China, a Nationwide, Multicenter DXA Survey. J Bone Min Res. 2019;34(10):1789\u201397. https:\/\/doi.org\/10.1002\/jbmr.3757.","journal-title":"J Bone Min Res"},{"issue":"7","key":"2338_CR5","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1097\/JS9.0000000000000411","volume":"109","author":"X-Q Zheng","year":"2023","unstructured":"Zheng X-Q, Xu L, Huang J, Zhang C-G, Yuan W-Q. Incidence and cost of vertebral fracture in urban China: a 5-year population-based cohort study. Int J Surg. 2023;109(7):1910\u20138. https:\/\/doi.org\/10.1097\/JS9.0000000000000411.","journal-title":"Int J Surg"},{"issue":"9","key":"2338_CR6","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00198-025-07588-w","volume":"36","author":"M Zoulakis","year":"2025","unstructured":"Zoulakis M, Johansson H, Harvey NC, Axelsson KF, Litsne H, Johansson L, et al. Effect of FRAXplus adjustments on fracture risk reclassification in older Swedish women-results from the SUPERB-study. Osteoporos Int. 2025;36(9):1649\u201359. https:\/\/doi.org\/10.1007\/s00198-025-07588-w.","journal-title":"Osteoporos Int"},{"issue":"5","key":"2338_CR7","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.clnu.2024.03.032","volume":"43","author":"J Pan","year":"2024","unstructured":"Pan J, Xu G, Zhai Z, Wang JSQ, Huang X, et al. Geriatric nutritional risk index as a predictor for fragility fracture risk in the elderly with type 2 diabetes mellitus: A 9-year ambispective longitudinal cohort study. Clin Nutr. 2024;43(5):1125\u201335. https:\/\/doi.org\/10.1016\/j.clnu.2024.03.032.","journal-title":"Clin Nutr"},{"issue":"1","key":"2338_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12902-024-01792-1","volume":"24","author":"D Huang","year":"2024","unstructured":"Huang D, He Q, Pan J, Zhai Z, Wang JSQ, et al. Systemic immune-inflammatory index predicts fragility fracture risk in postmenopausal anemic females with type 2 diabetes mellitus: evidence from a longitudinal cohort study. BMC Endocr Disord. 2024;24(1):256. https:\/\/doi.org\/10.1186\/s12902-024-01792-1.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"2338_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12902-025-01889-1","volume":"25","author":"J Lu","year":"2025","unstructured":"Lu J, Wei F, Sun J, Zhai Z, Pan J, Huang S, et al. Systemic immune-inflammation index to albumin (SII\/ALB) ratio as a novel dual-dimensional powerful predictor for hip fractures in elderly females with diabetes: a postmenopausal longitudinal cohort study. BMC Endocr Disord. 2025;25(1):57. https:\/\/doi.org\/10.1186\/s12902-025-01889-1.","journal-title":"BMC Endocr Disord"},{"issue":"38","key":"2338_CR10","doi-asserted-by":"publisher","first-page":"41370","DOI":"10.18632\/oncotarget.5629","volume":"6","author":"X Chen","year":"2015","unstructured":"Chen X, Xue L, Wang W, Chen H, Zhang W, Liu K, et al. Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte, and platelet in patients with gastric carcinoma: a retrospective cohort study. Oncotarget. 2015;6(38):41370\u201382. https:\/\/doi.org\/10.18632\/oncotarget.5629.","journal-title":"Oncotarget"},{"key":"2338_CR11","doi-asserted-by":"publisher","unstructured":"Xu H, Zheng X, Ai J. Lu Yang. Hemoglobin, albumin, lymphocyte, and platelet (HALP) score and cancer prognosis: a systematic review and meta-analysis of 13,110 patients. Int Immunopharmacol. 2023 Jan;114:109496. https:\/\/doi.org\/10.1016\/j.intimp.2022.109496.","DOI":"10.1016\/j.intimp.2022.109496"},{"issue":"1","key":"2338_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","volume":"133","author":"T Guenter Weiss","year":"2019","unstructured":"Guenter Weiss T, Ganz, Lawrence T, Goodnough. Anemia of inflammation. Blood. 2019;133(1):40\u201350. https:\/\/doi.org\/10.1182\/blood-2018-06-856500.","journal-title":"Blood"},{"issue":"6","key":"2338_CR13","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/sj.ejcn.1602779","volume":"62","author":"A Coin","year":"2008","unstructured":"Coin A, Perissinotto E, Enzi G, Zamboni M, Inelmen EM, Frigo AC, et al. Predictors of low bone mineral density in the elderly: the role of dietary intake, nutritional status and sarcopenia. Eur J Clin Nutr. 2008;62(6):802\u20139. https:\/\/doi.org\/10.1038\/sj.ejcn.1602779.","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"2338_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s40520-025-02991-z","volume":"37","author":"J Olivier Lamy","year":"2025","unstructured":"Olivier Lamy J, Everts-Graber. Elena Gonzalez Rodriguez. Denosumab for osteoporosis treatment: when, how, for whom, and for how long. A pragmatic approach. Aging Clin Exp Res. 2025;37(1):70. https:\/\/doi.org\/10.1007\/s40520-025-02991-z.","journal-title":"Aging Clin Exp Res"},{"issue":"3","key":"2338_CR15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1160\/TH14-12-1067","volume":"114","author":"R Mark","year":"2015","unstructured":"Mark R, Thomas, Robert F, Storey. The role of platelets in inflammation. Thromb Haemost. 2015;114(3):449\u2013. https:\/\/doi.org\/10.1160\/TH14-12-1067. \u200958.","journal-title":"Thromb Haemost"},{"issue":"4","key":"2338_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00774-016-0773-8","volume":"35","author":"D-Q Li","year":"2017","unstructured":"Li D-Q, Wan Q-L, Pathak JL, Li Z-B. Platelet-derived growth factor BB enhances osteoclast formation and osteoclast precursor cell chemotaxis. J Bone Min Metab. 2017;35(4):355\u201365. https:\/\/doi.org\/10.1007\/s00774-016-0773-8.","journal-title":"J Bone Min Metab"},{"issue":"1","key":"2338_CR17","doi-asserted-by":"publisher","first-page":"e0313842","DOI":"10.1371\/journal.pone.0313842","volume":"20","author":"T Abdussamed Vural","year":"2025","unstructured":"Abdussamed Vural T, Dolanbay HY. Hemoglobin, albumin, lymphocyte and platelet (HALP) score for predicting early and late mortality in elderly patients with proximal femur fractures. PLoS ONE. 2025;20(1):e0313842. https:\/\/doi.org\/10.1371\/journal.pone.0313842.","journal-title":"PLoS ONE"},{"key":"2338_CR18","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539\u201353. https:\/\/doi.org:\/10.1002\/(SICI)1096-9136(199807)15:7%3C539::AID-DIA668%3E3.0.CO;2-S."},{"issue":"3","key":"2338_CR19","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/ijms23031376","volume":"23","author":"C-H Cheng","year":"2022","unstructured":"Cheng C-H, Chen L-R, Chen K-H. Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover. Int J Mol Sci. 2022;23(3):1376. https:\/\/doi.org\/10.3390\/ijms23031376.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2338_CR20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s11914-021-00702-x","volume":"19","author":"MMN Laoise","year":"2021","unstructured":"Laoise MMN. Osteocytes and Estrogen Deficiency. Curr Osteoporos Rep. 2021;19(6):592\u2013603. https:\/\/doi.org\/10.1007\/s11914-021-00702-x.","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"2338_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.23736\/S1973-9087.25.08894-X","volume":"61","author":"MD Monaco","year":"2025","unstructured":"Monaco MD, Bardesono CCF, Minetto MA, Busso C, Giuseppe Massazza. Prevalent vertebral fractures and the diabetic bone paradox in women who sustain a hip fracture: a cross-sectional study. Eur J Phys Rehabil Med. 2025;61(3):543\u201350. https:\/\/doi.org\/10.23736\/S1973-9087.25.08894-X.","journal-title":"Eur J Phys Rehabil Med"},{"issue":"8","key":"2338_CR22","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00198-021-05855-0","volume":"32","author":"J Paul","year":"2021","unstructured":"Paul J, Devarapalli V, Johnson JT, Cherian KE, Jebasingh FK, Asha HS, et al. Do proximal hip geometry, trabecular microarchitecture, and prevalent vertebral fractures differ in postmenopausal women with type 2 diabetes mellitus? A cross-sectional study from a teaching hospital in southern India. Osteoporos Int. 2021;32(8):1585\u201393. https:\/\/doi.org\/10.1007\/s00198-021-05855-0.","journal-title":"Osteoporos Int"},{"key":"2338_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.108158","author":"S Mohit","year":"2026","unstructured":"Mohit S, Verma V, Venkatesh S, Nityanand. Immuno-microbial crosstalk in aplastic anemia: Role of gut and viral triggers. Microb Pathog. 2026. https:\/\/doi.org\/10.1016\/j.micpath.2025.108158. Jan:210:108158.","journal-title":"Microb Pathog"},{"issue":"1","key":"2338_CR24","doi-asserted-by":"publisher","first-page":"e202100683","DOI":"10.1002\/cbdv.202100683","volume":"19","author":"C Canan Gulmez","year":"2022","unstructured":"Canan Gulmez C, Altinkaynak M, Turk N, Ozdemir OA. Hemoglobin-Inorganic Hybrid Nanoflowers with Different Metal Ions as Potential Oxygen Carrying Systems. Chem Biodivers. 2022;19(1):e202100683. https:\/\/doi.org\/10.1002\/cbdv.202100683.","journal-title":"Chem Biodivers"},{"issue":"2","key":"2338_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/onc.2012.583","volume":"33","author":"U Kumari","year":"2014","unstructured":"Kumari U, Ya Jun W, Huat Bay B, Lyakhovich A. Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi anemia cells. Oncogene. 2014;33(2):165\u201372. https:\/\/doi.org\/10.1038\/onc.2012.583.","journal-title":"Oncogene"},{"issue":"22","key":"2338_CR26","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.21037\/atm-22-4603","volume":"10","author":"L Dong Wang","year":"2022","unstructured":"Dong Wang L, Liu Z, Qu B, Zhang X, Gao W, Huang, et al. Hypoxia-inducible factor 1\u03b1 enhances RANKL-induced osteoclast differentiation by upregulating the MAPK pathway. Ann Transl Med. 2022;10(22):1227. https:\/\/doi.org\/10.21037\/atm-22-4603.","journal-title":"Ann Transl Med"},{"issue":"4","key":"2338_CR27","first-page":"689","volume":"16","author":"K Ishida","year":"2005","unstructured":"Ishida K, Masayoshi Yamaguchi. Albumin regulates Runx2 and alpha1 (I) collagen mRNA expression in osteoblastic cells: comparison with insulin-like growth factor-I. Int J Mol Med. 2005;16(4):689\u201394.","journal-title":"Int J Mol Med"},{"issue":"12","key":"2338_CR28","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1002\/jbmr.234","volume":"25","author":"H-W Shoshana Yakar","year":"2010","unstructured":"Shoshana Yakar H-W, Courtland D, Clemmons. IGF-1 and bone: New discoveries from mouse models. J Bone Min Res. 2010;25(12):2543\u201352. https:\/\/doi.org\/10.1002\/jbmr.234.","journal-title":"J Bone Min Res"},{"key":"2338_CR29","doi-asserted-by":"publisher","unstructured":"Mark R, Edwards P, Sultan N, Karmali S, Ramani Moonesinghe, et al. Metabolic dysfunction in lymphocytes promotes postoperative morbidity. Clin Sci (Lond). 2015;129(5):423\u2009\u2013\u200937. https:\/\/doi.org\/10.1042\/CS20150024.","DOI":"10.1042\/CS20150024"},{"issue":"5","key":"2338_CR30","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/03009742.2017.1416667","volume":"47","author":"H Yoshida","year":"2018","unstructured":"Yoshida H, Suzuki M, Tanaka K, Takeda S, Yogo K, Matsumoto Y. An anti-interleukin-6 receptor antibody prevents bone structural and strength loss in collagen-induced arthritis mice. Scand J Rheumatol. 2018;47(5):384\u201391. https:\/\/doi.org\/10.1080\/03009742.2017.1416667.","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"2338_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/alcalc\/agad026","volume":"58","author":"X Wang","year":"2023","unstructured":"Wang X, Lu L, Chen X, Liang Y. Ying Xie 1, Xijie Yu. The role and mechanism of tumor necrosis factor-alpha in alcohol-induced bone loss. Alcohol Alcohol. 2023;58(4):375\u201384. https:\/\/doi.org\/10.1093\/alcalc\/agad026.","journal-title":"Alcohol Alcohol"},{"issue":"5","key":"2338_CR32","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/jcb.21360","volume":"102","author":"B Weicht","year":"2007","unstructured":"Weicht B, Maitz P, Kandler B, Fischer MB, Watzek G, Gruber R. Activated platelets positively regulate RANKL-mediated osteoclast differentiation. J Cell Biochem. 2007;102(5):1300\u20137. https:\/\/doi.org\/10.1002\/jcb.21360.","journal-title":"J Cell Biochem"},{"issue":"1","key":"2338_CR33","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s11033-025-10632-x","volume":"52","author":"SA Kavitha","year":"2025","unstructured":"Kavitha SA, Zainab S, Muthyalaiah YS. Cordelia Mano John, Sumathy Arockiasamy. Mechanism and implications of advanced glycation end products (AGE) and its receptor RAGE axis as crucial mediators linking inflammation and obesity. Mol Biol Rep. 2025;52(1):556. https:\/\/doi.org\/10.1007\/s11033-025-10632-x.","journal-title":"Mol Biol Rep"},{"issue":"10","key":"2338_CR34","doi-asserted-by":"publisher","first-page":"111813","DOI":"10.4239\/wjd.v16.i10.111813","volume":"16","author":"Z-P Li","year":"2025","unstructured":"Li Z-P, Luo C, Yu X-M, Ye L-Y, Sun D, Duan C-Z, et al. Diabetic bone fragility through advanced glycation end product-collagen axis: Mechanisms and therapy of sodium glucose cotransporter 2 inhibitors. World J Diabetes. 2025;16(10):111813. https:\/\/doi.org\/10.4239\/wjd.v16.i10.111813.","journal-title":"World J Diabetes"},{"issue":"10","key":"2338_CR35","doi-asserted-by":"publisher","first-page":"e15357","DOI":"10.1111\/1756-185X.15357","volume":"27","author":"I Majda","year":"2024","unstructured":"Majda I, Khoury. Osteoporosis and inflammation: Cause to effect or comorbidity? Int J Rheum Dis. 2024;27(10):e15357. https:\/\/doi.org\/10.1111\/1756-185X.15357.","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"2338_CR36","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3390\/nu15051159","volume":"15","author":"FSB Keller","year":"2023","unstructured":"Keller FSB, Gressies C, Schuetz P. Inflammation and Nutrition: Friend or Foe? Nutrients. 2023;15(5):1159. https:\/\/doi.org\/10.3390\/nu15051159.","journal-title":"Nutrients"},{"issue":"16","key":"2338_CR37","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.3390\/jcm14165662","volume":"14","author":"C Geert Meermans, Jeroen","year":"2025","unstructured":"Geert Meermans, Jeroen C, van Egmond. Malnutrition in Older Hip Fracture Patients: Prevalence, Pathophysiology, Clinical Outcomes, and Treatment-A Systematic Review. J Clin Med. 2025;14(16):5662. https:\/\/doi.org\/10.3390\/jcm14165662.","journal-title":"J Clin Med"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02338-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02338-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02338-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T03:59:36Z","timestamp":1786334376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02338-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2338"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02338-3","relation":{"references":[{"id-type":"doi","id":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","asserted-by":"subject"}]},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol received approval from the Ethics Committee of the Guangxi Academy of Medical Sciences & the People\u2019s Hospital of Guangxi Zhuang Autonomous Region (Center ethics approval No. Ethics-KY-IIT-2023-60 for \u201cThe Ambispective Cohort Study on Clinical Characteristics and Prognosis in Patients with Immunoinflammation and Metabolic Diseases\u201d). Written informed consent was obtained from all individual participants included in the study. The research was conducted in compliance with the ethical principles outlined in the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Human ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"229"}}